ResMed | RMD - Zinsaufwendungen Für Schuld

Aktienkurs
225.59
Täglich Wechseln
-2.38 -1.04%
Monatlich
-10.35%
Jährlich
1.20%
Q1 Prognose
219.21




Zinsaufwendungen Für Schuld Veränderung Datum
Ansell USD 20.6M 300K 2025-12
Artivion USD 5.53M 589K 2025-12
AtriCure USD 1.33M 17K 2025-09
Baxter International USD 58M 14M 2025-09
Cochlear AUD 6.3M 3.65M 2025-12
Cooper Companies USD 22.4M 2M 2025-12
CSL USD 215M 111M 2025-12
Dexcom USD 4.7M 0 2025-09
Edwards Lifesciences USD 38.6M 1.2M 2025-09
Fisher Paykel Healthcare NZD 5.5M 700K 2025-12
Globus Medical USD 17K 5.1B 2025-12
Haemonetics USD 7.21M 3.14M 2025-09
Hologic USD 27.6M 1000K 2025-12
Idexx Laboratories USD 10.08M 1.24M 2025-09
Inogen 1.03M 384K 2025-03
Insulet USD 9.2M 2.2M 2025-12
Integra LifeSciences USD 23.67M 953K 2025-12
Intuitive Surgical USD 19.35B 811.4M 2025-09
Masimo USD 7.5M 1.3M 2025-12
Medtronic USD 181M 0 2025-12
Philips EUR 109M 31M 2025-12
Ramsay Health Care AUD 300.6M 15.5M 2025-12
ResMed USD 8.79M 14.55M 2025-09
Sigma Healthcare AUD 7.97M 365K 2024-01
Sonic Healthcare AUD 86.91M 43.94M 2024-12
Steris USD 14.9M 0 2025-12
Teleflex USD 28.15M 3.69M 2025-12
Thermo Fisher Scientific USD 365M 18M 2025-12